Dianthus Therapeutics Stock Price History
DNTH Stock | 23.83 0.03 0.13% |
Below is the normalized historical share price chart for Dianthus Therapeutics extending back to June 21, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Dianthus Therapeutics stands at 23.83, as last reported on the 29th of November, with the highest price reaching 23.99 and the lowest price hitting 23.07 during the day.
If you're considering investing in Dianthus Stock, it is important to understand the factors that can impact its price. Dianthus Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0416, which denotes the company had a -0.0416% return per unit of standard deviation over the last 3 months. Dianthus Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Dianthus Therapeutics' Standard Deviation of 3.83, coefficient of variation of (1,863), and Mean Deviation of 2.81 to check the risk estimate we provide.
As of now, Dianthus Therapeutics' Total Stockholder Equity is increasing as compared to previous years. The Dianthus Therapeutics' current Stock Based Compensation is estimated to increase to about 3.8 M, while Common Stock Shares Outstanding is projected to decrease to under 3.2 M. . The current Price To Sales Ratio is estimated to decrease to 18.02. The current Price Earnings Ratio is estimated to decrease to -1.29. Dianthus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 12th of September 2023 | 200 Day MA 26.1817 | 50 Day MA 26.8238 |
Dianthus |
Sharpe Ratio = -0.0416
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | DNTH |
Estimated Market Risk
3.88 actual daily | 34 66% of assets are more volatile |
Expected Return
-0.16 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Dianthus Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Dianthus Therapeutics by adding Dianthus Therapeutics to a well-diversified portfolio.
Price Book 2.0873 | Enterprise Value Ebitda (7.35) | Price Sales 131.438 | Shares Float 13.6 M | Wall Street Target Price 51.8 |
Dianthus Therapeutics Stock Price History Chart
There are several ways to analyze Dianthus Stock price data. The simplest method is using a basic Dianthus candlestick price chart, which shows Dianthus Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | November 7, 2024 | 29.9 |
Lowest Price | November 21, 2024 | 20.27 |
Dianthus Therapeutics November 29, 2024 Stock Price Synopsis
Various analyses of Dianthus Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Dianthus Stock. It can be used to describe the percentage change in the price of Dianthus Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Dianthus Stock.Dianthus Therapeutics Price Daily Balance Of Power | (0.03) | |
Dianthus Therapeutics Price Action Indicator | 0.28 | |
Dianthus Therapeutics Price Rate Of Daily Change | 1.00 |
Dianthus Therapeutics November 29, 2024 Stock Price Analysis
Dianthus Stock Price History Data
The price series of Dianthus Therapeutics for the period between Sat, Aug 31, 2024 and Fri, Nov 29, 2024 has a statistical range of 9.63 with a coefficient of variation of 7.44. Under current investment horizon, the daily prices are spread out with arithmetic mean of 27.04. The median price for the last 90 days is 27.81. The company completed 1:16 stock split on 12th of September 2023.Open | High | Low | Close | Volume | ||
11/29/2024 | 23.81 | 23.99 | 23.07 | 23.83 | ||
11/27/2024 | 23.81 | 23.99 | 23.07 | 23.83 | 186,580 | |
11/26/2024 | 23.24 | 24.24 | 22.89 | 23.86 | 170,510 | |
11/25/2024 | 22.85 | 24.30 | 22.85 | 23.45 | 338,195 | |
11/22/2024 | 20.37 | 22.39 | 20.37 | 22.34 | 283,433 | |
11/21/2024 | 20.88 | 20.98 | 19.85 | 20.27 | 293,431 | |
11/20/2024 | 22.09 | 22.45 | 20.53 | 20.77 | 194,957 | |
11/19/2024 | 23.09 | 23.62 | 21.92 | 22.27 | 184,565 | |
11/18/2024 | 23.11 | 24.10 | 22.88 | 23.60 | 277,857 | |
11/15/2024 | 25.55 | 25.93 | 22.19 | 23.36 | 627,804 | |
11/14/2024 | 26.49 | 27.56 | 25.35 | 25.49 | 1,850,880 | |
11/13/2024 | 28.14 | 28.56 | 25.69 | 26.35 | 239,616 | |
11/12/2024 | 27.41 | 28.01 | 26.07 | 27.68 | 696,592 | |
11/11/2024 | 29.94 | 29.94 | 27.40 | 27.75 | 225,157 | |
11/08/2024 | 32.25 | 32.27 | 28.27 | 29.06 | 168,296 | |
11/07/2024 | 29.71 | 30.13 | 29.22 | 29.90 | 194,529 | |
11/06/2024 | 29.85 | 30.00 | 28.52 | 29.41 | 241,718 | |
11/05/2024 | 28.34 | 29.19 | 28.14 | 28.75 | 88,848 | |
11/04/2024 | 28.03 | 29.06 | 27.45 | 28.28 | 135,563 | |
11/01/2024 | 28.24 | 28.92 | 27.42 | 28.01 | 154,013 | |
10/31/2024 | 27.83 | 28.06 | 27.41 | 27.86 | 100,429 | |
10/30/2024 | 27.50 | 28.32 | 27.50 | 27.96 | 63,120 | |
10/29/2024 | 27.94 | 27.95 | 27.17 | 27.75 | 78,183 | |
10/28/2024 | 28.23 | 29.04 | 27.97 | 28.12 | 118,012 | |
10/25/2024 | 28.13 | 29.06 | 27.68 | 27.71 | 106,163 | |
10/24/2024 | 27.04 | 28.36 | 26.94 | 27.94 | 164,812 | |
10/23/2024 | 27.75 | 28.17 | 26.83 | 26.94 | 367,562 | |
10/22/2024 | 27.97 | 28.50 | 27.69 | 27.92 | 68,665 | |
10/21/2024 | 28.98 | 29.26 | 28.24 | 28.38 | 166,237 | |
10/18/2024 | 28.28 | 29.55 | 28.18 | 29.05 | 212,707 | |
10/17/2024 | 27.75 | 28.27 | 27.04 | 28.03 | 264,543 | |
10/16/2024 | 27.75 | 28.00 | 26.74 | 27.97 | 149,172 | |
10/15/2024 | 25.41 | 28.06 | 24.97 | 27.54 | 175,361 | |
10/14/2024 | 27.58 | 27.94 | 24.93 | 25.43 | 311,822 | |
10/11/2024 | 28.31 | 28.97 | 27.41 | 27.50 | 373,686 | |
10/10/2024 | 27.88 | 28.62 | 27.54 | 28.32 | 200,097 | |
10/09/2024 | 28.05 | 28.34 | 27.40 | 28.10 | 237,888 | |
10/08/2024 | 26.38 | 28.87 | 26.22 | 27.99 | 454,143 | |
10/07/2024 | 28.29 | 28.29 | 25.63 | 26.48 | 206,409 | |
10/04/2024 | 28.15 | 28.50 | 27.72 | 28.00 | 495,676 | |
10/03/2024 | 28.10 | 28.10 | 26.99 | 27.46 | 261,775 | |
10/02/2024 | 27.18 | 28.88 | 27.18 | 27.98 | 280,963 | |
10/01/2024 | 27.18 | 27.96 | 26.17 | 27.88 | 297,305 | |
09/30/2024 | 27.00 | 27.73 | 27.00 | 27.38 | 159,579 | |
09/27/2024 | 27.36 | 27.72 | 26.67 | 27.24 | 101,970 | |
09/26/2024 | 26.96 | 27.45 | 26.61 | 27.02 | 109,288 | |
09/25/2024 | 28.07 | 28.81 | 26.51 | 26.69 | 272,981 | |
09/24/2024 | 26.59 | 28.04 | 26.19 | 27.85 | 175,674 | |
09/23/2024 | 28.18 | 28.65 | 26.00 | 26.17 | 156,026 | |
09/20/2024 | 27.84 | 29.18 | 27.68 | 28.00 | 1,151,089 | |
09/19/2024 | 27.03 | 28.28 | 26.58 | 28.10 | 214,132 | |
09/18/2024 | 25.99 | 27.09 | 25.69 | 26.00 | 153,121 | |
09/17/2024 | 26.73 | 26.81 | 25.20 | 25.99 | 189,056 | |
09/16/2024 | 29.37 | 29.58 | 26.40 | 26.42 | 142,146 | |
09/13/2024 | 28.24 | 29.18 | 27.99 | 28.96 | 159,043 | |
09/12/2024 | 27.86 | 27.96 | 27.20 | 27.81 | 80,494 | |
09/11/2024 | 27.63 | 28.11 | 27.09 | 27.57 | 81,103 | |
09/10/2024 | 27.89 | 28.59 | 27.58 | 27.80 | 97,585 | |
09/09/2024 | 26.79 | 28.68 | 26.41 | 27.85 | 137,461 | |
09/06/2024 | 27.81 | 27.81 | 26.37 | 26.62 | 132,349 | |
09/05/2024 | 28.07 | 29.06 | 27.63 | 27.98 | 115,427 |
About Dianthus Therapeutics Stock history
Dianthus Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Dianthus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Dianthus Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Dianthus Therapeutics stock prices may prove useful in developing a viable investing in Dianthus Therapeutics
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 5.2 M | 3.2 M | |
Net Loss | -25.6 M | -26.9 M |
Dianthus Therapeutics Quarterly Net Working Capital |
|
Dianthus Therapeutics Stock Technical Analysis
Dianthus Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Latest Portfolios Now
Latest PortfoliosQuick portfolio dashboard that showcases your latest portfolios |
All Next | Launch Module |
Dianthus Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Dianthus Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Dianthus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Dianthus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.03) | |||
Jensen Alpha | (0.40) | |||
Total Risk Alpha | (0.79) | |||
Treynor Ratio | (0.14) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Dianthus Stock analysis
When running Dianthus Therapeutics' price analysis, check to measure Dianthus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dianthus Therapeutics is operating at the current time. Most of Dianthus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Dianthus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dianthus Therapeutics' price. Additionally, you may evaluate how the addition of Dianthus Therapeutics to your portfolios can decrease your overall portfolio volatility.
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |